Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Revenues $ 14,797,000 $ 17,840,000
Cost of sales 10,486,000 13,892,000
Gross profit 4,311,000 3,948,000
Operating expenses:    
Selling and administrative 4,725,000 4,536,000
Research and development 1,295,000 1,223,000
Total operating expenses 6,020,000 5,759,000
Operating loss (1,709,000) (1,811,000)
Interest income (expense), net (403,000) (328,000)
Net loss $ (2,112,000) $ (2,139,000)
Net loss per share - basic $ (0.13) $ (0.13)
Net loss per share - diluted $ (0.13) $ (0.13)
Weighted average number of common shares outstanding - basic 16,474,754 15,997,296
Weighted average number of common shares outstanding - diluted 16,474,754 15,997,296